Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines

Abstract This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. In the absence of high-level evidence base for follow-up practices, the duration and frequency are often at the discretion of local centres. By reviewing the existing literature and collating experience from varying practices across the UK, this paper provides recommendations on the work up and management of lateral skull base cancer based on the existing evidence base for this rare condition. Recommendations • Patients should be followed up to a minimum of five years with a prolonged follow-up for selected patients. (G) • Patients should be followed up at least two monthly in the first two years and three to six monthly in the subsequent years. (G) • Patients should be seen in dedicated multidisciplinary head and neck oncology clinics. (G) • Patients should be followed up by dedicated multidisciplinary clinical teams. (G) • The multidisciplinary follow-up team should include clinical nurse specialists, speech and language therapists, dietitians and other allied health professionals in the role of key workers. (G) • Clinical assessment should include adequate clinical examination including fibre-optic rigid or flexible nasopharyngolaryngoscopy. (R) • Magnetic resonance imaging and positron emission tomography combined with computed tomography imaging should be used when recurrence is suspected. (R) • Narrow band imaging can be used in the follow-up in selected sites. (R) • Second primary tumours should be part of rationale of follow-up and therefore adequate screening strategies should be used to detect them. (G) • Patients should be educated with regard to the appearance and detection of recurrences. (G) • Patients with persistent pain should be investigated to exclude recurrent disease. (R) • Patients should be offered support with tobacco and alcohol cessation services. (R)

[1]  P. Bradley,et al.  European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer , 2014, European Archives of Oto-Rhino-Laryngology.

[2]  E. Genden,et al.  Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma , 2013, European Archives of Oto-Rhino-Laryngology.

[3]  G. Cook,et al.  Can 18F-FDG PET/CT Reliably Assess Response to Primary Treatment of Head and Neck Cancer? , 2013, Clinical nuclear medicine.

[4]  R. Hewitt,et al.  Follow-up in head and neck cancer: patients' perspective. , 2012, International journal of health care quality assurance.

[5]  R. Hewitt,et al.  The follow-up of patients with head and neck cancer: an analysis of 1,039 patients , 2011, European Archives of Oto-Rhino-Laryngology.

[6]  M. Quer,et al.  Risk of third and fourth tumors in patients with head and neck cancer , 2010, Head & neck.

[7]  M. O'Connell,et al.  Current trends in the follow-up of head and neck cancer patients in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  Giorgio Peretti,et al.  Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients , 2010, European Archives of Oto-Rhino-Laryngology.

[9]  G. Funk,et al.  The role of pain in head and neck cancer recurrence and survivorship. , 2009, Archives of otolaryngology--head & neck surgery.

[10]  P. Bradley,et al.  Consensus statement on management in the UK: Transoral laser assisted microsurgical resection of early glottic cancer , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[11]  O. Guntinas-Lichius,et al.  Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer , 2009, Acta oto-laryngologica.

[12]  C. McConkey,et al.  A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[13]  R. Morton,et al.  On completion of curative treatment of head and neck cancer: why follow up? , 2004, Current opinion in otolaryngology & head and neck surgery.

[14]  K. Wallner,et al.  Postradiotherapy surveillance practice for head and neck squamous cell carcinoma—too much for too little? , 2003, Head & neck.

[15]  N. James,et al.  Improving outcomes in head and neck cancer. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

[16]  I. Haas,et al.  The dilemma of follow-up in head and neck cancer patients , 2001, European Archives of Oto-Rhino-Laryngology.

[17]  M. Quer,et al.  Second neoplasm in patients with head and neck cancer , 1999, Head & neck.

[18]  K. Barmwater Einige Fälle von Endstheliom in den oberen Luft-und Speisewegen , 1931 .